Dr. Ziwen Jiang received exactly $2,000,000 from the Cancer Prevention & Research Institute of Texas (CPRIT) for his study on Engineered Antibody Tools for Targeted Regulation of Cancer-associated Proteins and Organelles. This study focuses on the development of antibody-based tools that control particular components of the autophagy process in human cells. As autophagy, this process is a natural recycling system that eliminates damaged proteins and cellular components and also plays an important role in protecting humans from disease and cancer.

Dr. Jiang’s research seeks to design specific antibodies with the hope of targeting cancer-related proteins, clattered cells, damaged organelles, and other complications that have remained challenging to address while using standard treatments. In addition to this, Dr. Jiang’s research intends to explain how these cellular mechanisms contribute to the development of cancer.

The long-term outcomes of this study will include forming new therapeutic antibodies, improved strategies to prevent cancer, and valuable tools for studying the development of diseases. Dr. Jiang’s study will also contribute to the field of Chemistry and Biochemistry.